Jie Wang, MD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Shanxi Province Cancer Hospital · Cancer Hospital Chinese Academy of Medical Science
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jie Wang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:29 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07668037 · Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC ImmunotherapyCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Non-Small Cell Carcinoma of Lung, Immunotherapy, Advanced Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT06897046 · Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLCCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Non-small Cell Lung Cancer (NSCLC), II-IIIB · principal investigator
- Ph1NCT06386705 · TSN084 Treating Patients With Advanced Malignant TumorsTyligand Bioscience (Shanghai) Limited · unknown · Malignant Neoplasm · principal investigator
- Ph2NCT06198907 · Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)Cancer Institute and Hospital, Chinese Academy of Medical Sciences · not yet recruiting · Non-Small-Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT05886439 · LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung CancerCancer Institute and Hospital, Chinese Academy of Medical Sciences · recruiting · Lung Cancer · principal investigator
- Ph3NCT05015608 · Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET AmplificationHutchison Medipharma Limited · completed · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT03432598 · Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung CancerBeiGene · completed · Locally Advanced Lung Cancer; Metastatic Lung Cancer · principal investigator
- Ph1NCT03301688 · The Pharmacokinetics and Safety of Single-dose and Parallel Comparisons in Patients With NSCLC Treated With JS001Shanghai Junshi Bioscience Co., Ltd. · completed · NSCLC · principal investigator
- Ph3NCT03196986 · mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung CancerBeijing Mabworks Biotech Co., Ltd. · completed · Non-small Cell Lung Cancer · principal investigator
- Ph4NCT03072121 · Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to RevascularizationJun Li · unknown · Coronary Artery Disease(CAD) · study director
- Ph4NCT03072082 · Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to RevascularizationJun Li · unknown · Coronary Artery Disease(CAD) · study director
- Ph4NCT01513070 · A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary StenosisGuang'anmen Hospital of China Academy of Chinese Medical Sciences · completed · Coronary Artery Stenosis, Coronary Heart Disease · study chair
- N/ANCT00974285 · Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV PatientsGuang'anmen Hospital of China Academy of Chinese Medical Sciences · unknown · Acquired Immune Deficiency Syndrome Virus, HIV Infections · study chair
- N/ANCT00974519 · The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS PatientsGuang'anmen Hospital of China Academy of Chinese Medical Sciences · unknown · Acquired Immune Deficiency Syndrome Virus, HIV Infections · study chair
- N/ANCT00974454 · Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)Guang'anmen Hospital of China Academy of Chinese Medical Sciences · unknown · Acquired Immune Deficiency Syndrome Virus, HIV Infections · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.